1380089-79-1

Upstream product

• 13421-00-6 5-chloro-2-iodo-benzoic acid 
• 43214-88-6 (3-methylisoxazol-5-yl)methyl acetate 
• 1380089-33-7 (4-bromo-3-methyl-1,2-oxazol-5-yl)methyl acetate 
• 1380089-34-8 (3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoxazol-5-yl)methyl acetate 
• 289039-82-3 methyl 5-chloro-2-iodo-benzoate 
• 1505453-60-0 methyl 5-chloro-2-(5-(hydroxymethyl)-3-methylisoxazol-4-yl)benzoate 
• 1505453-61-1 methyl 5-chloro-2-(5-formyl-3-methylisoxazol-4-yl)benzoate 
• 343338-28-3 (S)-2-methylpropane-2-sulfinamide 

Downstream Products

• 1505453-59-7 2-((4S)-6-(4-chlorophenyl)-1-methyl-8-(1-methyl-1H-pyrazol-4-yl)-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide 
• 1505453-81-5 C₂₆H₂₄ClN₅O₂ 

Relevant academic research and scientific papers

BENZO [C] ISOXAZOLOAZEPINE BROMODOMAIN INHIBITORS AND USES THEREOF

The present invention relates to compounds useful as inhibitors of bromodomain- containing proteins. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions

BROMODOMAIN INHIBITORS AND USES THEREOF

The present invention relates to compounds useful as inhibitors of bromodomain-containing proteins. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.